Extreme Biodiesel In (XTRM) fair value: what the stock is really worth
As of Sep 28, 2026: fair value of Extreme Biodiesel In $0.00, price $0.00, upside +0.0%, quality 24 out of 100. Calculated from audited financials with 26 valuation models and 37 quality factors, updated daily.
Watch Extreme Biodiesel In for free, get notified when fair value or trend changes. Plus fair value for all 35,000+ stocks, 14 days of Pro free, no card.Watch for freePro now: $1 first month
Extreme Biodiesel, Inc. engages in the development, marketing, and commercialization of bio-diesel fuel, home bio-diesel processors, and related products. The company is based in Corona, California.
Stock analysis
Extreme Biodiesel In (XTRM) currently trades at $0.0001, while our model-based Fair Value estimate is $0.0001, so the stock looks roughly fairly valued today (gap 0.0%).
Show more
Valuation
Bull case: the Growth DCF group reads highest at a median of $0.0001 per share, and 0 of the 5 models we run sit above the $0.0001 price.
Bear case: the DCF Models group reads lowest at $0.0001, and 5 of the 5 models stay below the price. Evidence for this calculation is low.
Quality & growth
The Quality Score stands at 24/100 (below-average quality), in the Real Estate sector.
Weak Growth: Revenue growth is weak, negative or inconsistent.
Extreme Biodiesel In reported revenue of $8.4M in FY2022 versus $77 in FY2013, a compound +262.8%/yr. Reported net income was $14.6K in FY2022.
Key figures
Market cap $246K · P/S ratio 3.35 · Net margin 0.2% · Return on equity −150% · Return on assets (EBIT) −8.8% · Operating margin −82.0% · Revenue growth (YoY) −49.1% · Free cash flow $1.4M.
Competitive moat
Our AI-assisted moat analysis scores the competitive advantage at 28 out of 100 (medium confidence).
What moves the price
The share trades at its 52-week high and at its 52-week low, currently above its 200-day average.
For context, the median of 10 Real Estate peers we cover trades at 6% fair-value upside, at 0%, XTRM screens richer than that median.
Fair Value models
Bear $0.0001Fair Value $0.0001Bull $0.0001
Model ⓘEach model values the company its own way (discounted cash flow, earnings, assets, dividends). The fair value above is their evidence-weighted blend, not the output of a single model.Bear ⓘBear = the cautious scenario: the same model computed with conservative anchors (lower growth, margins and valuation multiples). Together with Bull it frames a plausible valuation range, not a price target.BaseBull ⓘBull = the optimistic scenario: the same model computed with favourable anchors (higher growth, margins and valuation multiples). Together with Bear it frames a plausible valuation range, not a price target. If a model's bull case is above four times its base value, the table shows that limit with a > sign (like the overall Bull above): beyond it no assumption holds.Evidence ⓘEvidence = how well-backed THIS model's estimate is for this stock (0–100): how complete and reliable its input data are, and how well the model fits the company. The final Fair Value is an evidence-weighted blend, so better-evidenced models count more. Green ≥70, amber 50–69, grey below 50.
Growth Quality ⓘGrowth is valuable only when reinvestment earns attractive returns (Aswath Damodaran): sustainable growth depends on return on capital, reinvestment and efficiency. Basis: total company revenue over the periods shown on the cards (3Y/5Y/all years), not per share, so a merger can show up as a growth jump; per-share earnings growth is in the value-creation card.38/100
Revenue growth is weak, negative or inconsistent.
Revenue growth 1 year
−37.8%
Revenue growth 12 years ⓘMeasures the company's TOTAL revenue from reported annual statements: compound average growth per year (CAGR) from the fiscal year 3, 5 or N years back to the most recent comparable fiscal year. Not per share: buybacks do not change this number, and a merger can appear as a growth jump. Per-share growth (which does include buybacks) is in the value-creation card.
+46.1%
’10
’11
’12
’13
’14
’20
’21
’22
What shareholders gained per year (last 3 years) ⓘWhat the business itself delivers per year: earnings growth per share plus the dividend yield. This is what you get IF the market keeps valuing the stock the same way: it contains no assumption about the market changing its mind. Computed per share, so buybacks count and a merger does not pass as growth. For a company that pays no dividend it is pure earnings growth per share. Period: earnings growth per share as CAGR over the last 3 reported fiscal years (annual statements), plus the current dividend yield. The start value is the median of the three years around the start, so a single crisis year (a pandemic or a write-down) does not distort the rate.
−70.0%
Earnings growth per share plus dividend.
Earnings per share, growth per year−70.0%
Dividend (yield on the price)0.0%
Profit margin 2010 to 2022 ⓘOperating margin then vs now, from reported annual statements. A falling margin after a boom year is the classic peak-earnings signal: the growth rate then leans on an inflated base.−48% → 5%
Price, fair value, quality and upside side by side.
Free, no sign-up
Peer GroupⓘHow this stock ranks against its industry: the green marker is this stock, the band is the typical 25–75% peer range, and the tick is the median.Real Estate - Development · 566 stocks
Beats the industry median on 2/9 measures
Overall it trails its industry peers.
Valuation
Quality Score25 · Bottom 25%
Fair Value upside+0.0% · Below median
Profitability
Return on assets−23.8% · Bottom 25%
Net margin (TTM)0.2% · Below median
Operating margin (TTM)−82.0% · Bottom 25%
Growth and dividend
Revenue growth−49.1% · Bottom 25%
Valuation Multiplesvs Real Estate - Development median · lower = cheaper
For bloggers, editors and developers: paste this into your site or blog (a “Custom HTML” block in WordPress), it shows the current fair value and links back here. Free, plain HTML, and welcome. Full data streams (CSV/JSON) at /developers.
Cite: Fair Value Calculator (2026). "Extreme Biodiesel In Fair Value". https://www.fairvalue-calculator.com/stock/XTRM
Frequently asked questions
Is Extreme Biodiesel In (XTRM) overvalued or undervalued?
As of Sep 27, 2026, our model estimates a fair value of $0.0001 versus a price of $0.0001, about +0% upside (fairly valued).
What is the fair value of XTRM?
Our model-based fair value for Extreme Biodiesel In is $0.0001 (as of Sep 27, 2026), built from audited fundamentals. The current price: $0.0001.
What is the quality score of XTRM?
Extreme Biodiesel In has a Quality Score of 24/100. It measures business quality (profitability, growth, cash flow, balance-sheet strength, investment discipline, share issuance). Market factors such as price momentum and volatility do not enter the number; they are shown separately in the detail view.
What is the price target for Extreme Biodiesel In (XTRM)?
Our model-based price target is the fair value of $0.0001 (as of Sep 27, 2026) from 7 valuation models. It is a calculation from audited fundamentals, not an analyst target.
What is the Extreme Biodiesel In stock forecast for 2026?
Our models put fair value at $0.0001, about +0% upside versus a price of $0.0001 (fairly valued). The calculation is refreshed regularly with new filings.
What is the intrinsic value of Extreme Biodiesel In (XTRM)?
Intrinsic value and fair value mean the same thing: what the business is worth on its numbers, independent of the share price. For Extreme Biodiesel In it is $0.0001 per share (as of Sep 27, 2026), against a price of $0.0001. It is the blended result of 7 valuation models (cash flow, earnings, asset, dividend).
Is Extreme Biodiesel In stock overvalued or undervalued in 2026?
As of Sep 27, 2026, XTRM trades below its calculated fair value: price $0.0001, fair value $0.0001, a gap of about +0% (fairly valued). The calculation is refreshed with each new quarterly report, so the verdict can change during the year.
Is fair value the same as the market price of XTRM?
No. The price is what the market pays today ($0.0001); the fair value is what the company's own numbers justify ($0.0001). For Extreme Biodiesel In the two are $0.0000 per share apart. That gap is exactly why we show both numbers side by side.
How much is Extreme Biodiesel In worth?
The market values Extreme Biodiesel In at about $246K (market capitalisation, as of Sep 27, 2026). Per share that is $0.0001; our models calculate a fair value of $0.0001 per share.
How solid is the balance sheet of Extreme Biodiesel In (XTRM)?
Balance-sheet figures for Extreme Biodiesel In (as of Sep 27, 2026): return on equity −149.6%. They feed the Quality Score of 24/100, which measures business quality independently of the share price.
How far is XTRM from its 52-week high?
Extreme Biodiesel In trades at $0.0001, at its 52-week high of $0.0001 and at the low of $0.0001 (as of Sep 25, 2026). Distance from the high says nothing about value: that is what the fair value of $0.0001 is for.
Which stocks are comparable to Extreme Biodiesel In?
From the same area (Real Estate) we also value Sun Hung Kai Properties Limited, China Resources Land Limited, CK Asset Holdings, Hongkong Land Holdings, among others. Each of them has its own fair-value calculation on this site using the same models, so the comparison is like for like.
Is Extreme Biodiesel In stock attractive at the current price?
The data as of Sep 27, 2026: price $0.0001, calculated fair value $0.0001 (+0%), Quality Score 24/100, from 7 models. Whether that fits your horizon and risk tolerance is your call. We provide the calculation, not investment advice.
How is the fair value of XTRM calculated?
We run Extreme Biodiesel In through 7 models from four families: discounted cash flow, earnings models, asset and balance-sheet models, and dividend models. Every model gets the same audited fundamentals; the result is the weighted average of $0.0001, with the spread shown as a cautious and an optimistic scenario.
Is it still worth investing in stocks now?
The global stock market currently sits 14.5 % above its aggregate fair value. Extreme Biodiesel In itself currently trades above fair value. An expensive market is no reason to stay out and no reason to buy everything at once: keep a broad savings plan running, buy single stocks only with money you can do without, and hold part of your money liquid while the market is high. The full picture including sectors is on is it worth investing now.
What is the share price of Extreme Biodiesel In (XTRM)?
The closing price on Sep 28, 2026 was $0.0001. Our model-based fair value is $0.0001, about +0% upside (fairly valued). We carry closing prices from our data provider, not a live tick.
What should I pay attention to with Extreme Biodiesel In right now?
The price sits close to our fair value, market and models broadly agree here, little valuation tension. Evidence is limited here (fewer models, shorter history), so the fair value is a rougher estimate than usual. As a real-estate business, asset- and dividend-based methods carry more weight here than a standard DCF.
Key figures of Extreme Biodiesel In
How large is the market capitalisation of Extreme Biodiesel In (XTRM)?
The market capitalisation of Extreme Biodiesel In is $246K. The stock-market value of the whole company: share price times number of shares. It is what the market asks for the entire business today.
What is the P/S ratio of Extreme Biodiesel In (XTRM)?
The price-to-sales ratio of Extreme Biodiesel In is 3.35 (last twelve months). Price to sales: market value relative to yearly revenue. Useful when profit is thin or distorted.
What is the net margin of Extreme Biodiesel In (XTRM)?
The net margin of Extreme Biodiesel In is 0.2% (fiscal year 2022). How much of every unit of revenue ends up as profit. 10% means 10 cents of profit per dollar of sales.
What is the return on equity of Extreme Biodiesel In (XTRM)?
The return on equity (ROE) of Extreme Biodiesel In is −150% (last twelve months). Profit relative to shareholders' equity, how efficiently the company works with its owners' money.
What is the EBIT return on assets of Extreme Biodiesel In (XTRM)?
On an EBIT basis the return on assets of Extreme Biodiesel In is −8.8% (avg 5y). Operating profit (EBIT) relative to everything the company owns, as a multi-year average. It describes the business model rather than one good or bad year.
What is the operating margin of Extreme Biodiesel In (XTRM)?
The operating margin of Extreme Biodiesel In is −82.0% (last twelve months). Profit from the core business (before interest and taxes) relative to revenue.
How fast is revenue growing at Extreme Biodiesel In (XTRM)?
Revenue at Extreme Biodiesel In is growing −49.1% versus a year earlier (3y avg +5,838%). How much revenue grew versus a year earlier (YoY). The 3-year average next to it puts the single year in context.
How much free cash flow does Extreme Biodiesel In (XTRM) generate?
The free cash flow of Extreme Biodiesel In is $1.4M (fiscal year 2022). The cash truly left after running and investing in the business, this is what pays dividends and buybacks.
How much net debt does Extreme Biodiesel In (XTRM) carry?
The net debt of Extreme Biodiesel In is $6.5M (fiscal year 2022, ≈ 4.5 yrs of FCF). Debt minus cash on hand. The note shows how many years of free cash flow could in theory pay it off.
Free · no account needed
Watch Extreme Biodiesel In in the live analysis
One click puts Extreme Biodiesel In on your watchlist: fair value and trend at a glance, plus comparison, the diversification check and the 35,000+ stock screener. You can also try 14 days of Pro there, no card.
Thin data
Sep 27, 2026